Flavocure Was Founded With A Focus On Non Cannabinoid Bioactive Phytochemical Properties Of Cannabisthe Company Recently Discovered Creserola Drug Which Recently Received Orphan Drug Approval By The Fda For The Treatment Of Acute Myeloid Leukemiain Collaboration With Some Of The Top Research Institutions In The Worldthe Company Continues To Embark On Discoveries With The Use Of Other Drugs For The Treatment Pancreatic Cancer And Glioblastoma Brain Cancer Most Recently Has Established Ongoing Collaboration With Harvard Medical School And The Dana Farber Cancer Instituteas Well As Ongoing Research With The University Of Maryland Medical School And Duke University
